LivaNova PLC
LIVN62.820USD
+0.740+1.19%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
3.43BMarket Cap
LossP/E TTM
More Details of LivaNova PLC Company
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
LivaNova PLC Info
Ticker SymbolLIVN
Company nameLivaNova PLC
IPO dateOct 19, 2015
CEOMakatsaria (Vladimir A)
Number of employees2900
Security typeOrdinary Share
Fiscal year-endOct 19
Address20 Eastbourne Terrace
CityLONDON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited Kingdom
Postal codeW2 6LG
Phone442033250662
Websitehttps://www.livanova.com/
Ticker SymbolLIVN
IPO dateOct 19, 2015
CEOMakatsaria (Vladimir A)
Company Executives of LivaNova PLC
Name
Name/Position
Position
Shareholding
Change
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
+15.05%
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
26.68K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
12.75K
--
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
+19.06%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
+49.63%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
-14.25%
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
8.52K
+4.49%
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
6.23K
-3.86%
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
5.67K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
1.94K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
32.57K
+15.05%
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
26.68K
--
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
12.75K
--
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
+19.06%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
9.06K
+49.63%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.03K
-14.25%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
188.47M
53.46%
Rest of World
97.27M
27.59%
Europe
66.78M
18.94%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.60%
PRIMECAP Management Company
8.14%
Millennium Management LLC
5.44%
Artisan Partners Limited Partnership
4.44%
Wellington Management Company, LLP
4.30%
Other
66.08%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.60%
PRIMECAP Management Company
8.14%
Millennium Management LLC
5.44%
Artisan Partners Limited Partnership
4.44%
Wellington Management Company, LLP
4.30%
Other
66.08%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.17%
Investment Advisor/Hedge Fund
36.44%
Hedge Fund
13.06%
Research Firm
3.19%
Pension Fund
2.29%
Bank and Trust
1.34%
Individual Investor
0.37%
Sovereign Wealth Fund
0.09%
Insurance Company
0.04%
Institutional Shareholding
Updated: Sun, Oct 5
Updated: Sun, Oct 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
562
56.86M
104.13%
-8.50M
2025Q2
564
56.85M
104.11%
-6.95M
2025Q1
581
56.61M
103.82%
-8.04M
2024Q4
586
56.98M
104.84%
-8.56M
2024Q3
563
55.15M
101.56%
-9.48M
2024Q2
546
57.21M
105.64%
-8.52M
2024Q1
547
58.00M
107.51%
-6.90M
2023Q4
532
56.62M
105.11%
-7.28M
2023Q3
527
56.14M
104.20%
-8.51M
2023Q2
529
55.56M
103.33%
-9.55M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.37M
11.67%
-150.58K
-2.31%
Jun 30, 2025
PRIMECAP Management Company
4.64M
8.5%
+32.94K
+0.71%
Jun 30, 2025
Millennium Management LLC
2.43M
4.44%
+360.76K
+17.47%
Jun 30, 2025
Artisan Partners Limited Partnership
1.25M
2.29%
+661.48K
+112.86%
Jun 30, 2025
Wellington Management Company, LLP
1.28M
2.34%
+805.32K
+170.32%
Jun 30, 2025
The Vanguard Group, Inc.
2.44M
4.47%
-214.69K
-8.09%
Jun 30, 2025
State Street Investment Management (US)
2.08M
3.81%
-17.41K
-0.83%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.61M
2.96%
+282.33K
+21.20%
Jun 30, 2025
AQR Capital Management, LLC
2.05M
3.75%
+478.52K
+30.45%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.43M
2.62%
+18.55K
+1.31%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.66%
JPMorgan Active Small Cap Value ETF
1.43%
Invesco NASDAQ Future Gen 200 ETF
0.5%
Simplify Health Care ETF
0.43%
Global X Aging Population ETF
0.42%
JPMorgan Fundamental Data Science Small Core ETF
0.37%
Avantis US Small Cap Equity ETF
0.34%
iShares U.S. Medical Devices ETF
0.34%
WisdomTree US SmallCap Fund
0.33%
Federated Hermes MDT Small Cap Core ETF
0.33%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.66%
JPMorgan Active Small Cap Value ETF
Proportion1.43%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.5%
Simplify Health Care ETF
Proportion0.43%
Global X Aging Population ETF
Proportion0.42%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.37%
Avantis US Small Cap Equity ETF
Proportion0.34%
iShares U.S. Medical Devices ETF
Proportion0.34%
WisdomTree US SmallCap Fund
Proportion0.33%
Federated Hermes MDT Small Cap Core ETF
Proportion0.33%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of LivaNova PLC?
The top five shareholders of LivaNova PLC are:
BlackRock Institutional Trust Company, N.A. holds 6.37M shares, accounting for 11.67% of the total shares.
PRIMECAP Management Company holds 4.64M shares, accounting for 8.50% of the total shares.
Millennium Management LLC holds 2.43M shares, accounting for 4.44% of the total shares.
Artisan Partners Limited Partnership holds 1.25M shares, accounting for 2.29% of the total shares.
Wellington Management Company, LLP holds 1.28M shares, accounting for 2.34% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 6.37M shares, accounting for 11.67% of the total shares.
PRIMECAP Management Company holds 4.64M shares, accounting for 8.50% of the total shares.
Millennium Management LLC holds 2.43M shares, accounting for 4.44% of the total shares.
Artisan Partners Limited Partnership holds 1.25M shares, accounting for 2.29% of the total shares.
Wellington Management Company, LLP holds 1.28M shares, accounting for 2.34% of the total shares.
What are the top three shareholder types of LivaNova PLC?
The top three shareholder types of LivaNova PLC are:
BlackRock Institutional Trust Company, N.A.
PRIMECAP Management Company
Millennium Management LLC
BlackRock Institutional Trust Company, N.A.
PRIMECAP Management Company
Millennium Management LLC
How many institutions hold shares of LivaNova PLC (LIVN)?
As of 2025Q3, 562 institutions hold shares of LivaNova PLC, with a combined market value of approximately 56.86M, accounting for 104.13% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 0.01%.
What is the biggest source of revenue for LivaNova PLC?
In FY2025Q2, the -- business generated the highest revenue for LivaNova PLC, amounting to -- and accounting for --% of total revenue.
